News + Filings Transactions
|
Siu Christine
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2022 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 15k | $7.66 | $114.9k | | 06/15/2022 |
| 06/23/2021 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 47.1k | $19.00 | $895.5k | | 04/12/2021 |
| 04/12/2021 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 7.1k | $0.00 | $0 | | 04/12/2021 |
| 12/09/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 10k | $0.59 | $5.9k | | 12/09/2019 |
| 12/09/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 901 | $60.05 | $54.1k | | 12/09/2019 |
| 12/09/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 9.1k | $59.62 | $542.5k | | 12/09/2019 |
| 12/04/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 8.8k | $58.60 | $515.7k | | 12/03/2019 |
| 12/04/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.2k | $59.39 | $71.3k | | 12/03/2019 |
| 12/04/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 10k | $0.59 | $5.9k | | 12/03/2019 |
| 12/03/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 600 | $57.82 | $34.7k | | 12/03/2019 |
| 12/03/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 5.4k | $58.95 | $318.3k | | 12/03/2019 |
| 12/03/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 4k | $59.65 | $238.6k | | 12/03/2019 |
| 12/03/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 10k | $0.59 | $5.9k | | 12/03/2019 |
| 11/22/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 9.4k | $54.71 | $514.2k | | 11/21/2019 |
| 11/22/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Common Stock | 10k | $0.59 | $5.9k | | 11/21/2019 |
| 11/22/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 601 | $55.29 | $33.2k | | 11/21/2019 |
| 11/21/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 200 | $56.00 | $11.2k | | 11/21/2019 |
| 11/21/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 24.8k | $55.12 | $1.4M | | 11/21/2019 |
| 11/21/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 10k | $0.59 | $5.9k | | 11/21/2019 |
| 11/21/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 25k | $0.59 | $14.8k | | 11/21/2019 |
| 07/10/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 5k | $39.37 | $196.8k | | 07/10/2019 |
| 07/10/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 5k | $0.59 | $3k | | 07/10/2019 |
| 06/26/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 17k | $0.59 | $10k | | 06/26/2019 |
| 06/05/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 300 | $31.03 | $9.3k | | 06/05/2019 |
| 06/05/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 13.4k | $30.10 | $404k | | 06/05/2019 |
| 06/05/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3.3k | $29.34 | $96.2k | | 06/05/2019 |
| 05/31/2019 | Eidos Therapeutics, Inc. | EIDX | Grant | Common Stock | 1.8k | $12.01 | $21.2k | | 06/05/2019 |
| 04/24/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 5k | $0.59 | $3k | | 04/24/2019 |
| 04/24/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 5k | $26.11 | $130.6k | | 04/24/2019 |
| 03/19/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 11.9k | $19.66 | $234.2k | | 03/19/2019 |
| 03/19/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 10.9k | $0.15 | $1.6k | | 03/19/2019 |
| 03/19/2019 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 34.7k | $0.59 | $20.5k | | 03/19/2019 |
| 11/30/2018 | Eidos Therapeutics, Inc. | EIDX | Grant | Common Stock | 1.1k | $12.01 | $13k | | 03/19/2019 |
| 11/05/2018 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (right to buy) | 55k | $13.20 | $726k | | 11/05/2018 |
|